A new systematic review and meta-analysis have shed light on the growing concern over the impact of cannabis use among adolescents, revealing a significant association with increased anxiety symptoms and disorders later in life. This comprehensive study, published in The American Journal of Drug and Alcohol Abuse, underscores the mental health risks posed by early cannabis consumption during a critical developmental period.
The research, conducted by a team from the Centre for Addiction and Mental Health in Toronto, aimed to explore the prospective relationship between cannabis use in adolescents and subsequent anxiety outcomes. Adolescence is a period of significant neurobiological and psychological development, making it a vulnerable time for individuals to be exposed to substances like cannabis, which can have long-lasting effects on mental health.
Darby Lowe, a PhD student at the University of California, Berkeley, highlighted the importance of focusing on cannabis use in younger populations, saying, “One critical area of exploration is cannabis’ impact among more vulnerable populations, such as adolescents, and its influence on critical outcomes, such as mental health.” Lowe emphasised the need to address knowledge gaps in this area, particularly regarding the potential long-term effects of cannabis use on mental health.
The meta-analysis incorporated data from six longitudinal studies, including over 11,000 adolescents. The findings were clear: adolescents who reported using cannabis were more than twice as likely to develop anxiety disorders later in life compared to those who did not use the drug. This increased risk persisted even after accounting for other variables such as comorbid substance use, suggesting a robust link between early cannabis use and later anxiety.
A qualitative review of 12 additional studies echoed these results. Nine of these studies found a significant association between adolescent cannabis use and increased anxiety symptoms later in life, regardless of whether an official anxiety disorder diagnosis was made. This consistent trend across multiple studies highlights the potential long-term mental health implications of cannabis use during adolescence.
Reflecting on these findings, Lowe shared insights from her research, noting, “We investigated cannabis use during early and late adolescence (13–19 years of age), a critical developmental stage during which substance use has a particularly significant impact on physical and mental health. Building on existing research that has described heightened anxiety amongst those who use cannabis, we tested whether early adolescent cannabis use would influence anxiety experiences in later life.”
The findings point out that while there is a growing body of evidence supporting the link between cannabis use and anxiety, the relationship is complex and multifactorial. The endocannabinoid system, which plays a crucial role in regulating mood, stress, and emotion, is particularly sensitive during adolescence. Cannabis, particularly its psychoactive component THC, can disrupt normal neurodevelopmental processes such as synaptic pruning and white matter development, potentially leading to adverse mental health outcomes.
Lowe further emphasised the importance of understanding moderating factors in this relationship: “Despite this finding, our research underscores the necessity of considering important moderating factors, from sex-based differences and early life trauma, to cannabis potency and research methodology, as these factors can all significantly influence and provide more nuanced insights into the cannabis-anxiety link.”
Interestingly, while the majority of studies included in the review found a significant relationship between cannabis use and anxiety, there were some exceptions. Three studies did not observe a significant link between adolescent cannabis use and increased levels of anxiety. These discrepancies underscore the need for further research to fully understand the nuances of this relationship, including factors such as the frequency of use, the specific cannabinoids involved, and individual differences in susceptibility.
Lowe expressed hope for future research and the potential for more informed public health strategies: “Moving forward, we aim to further contribute towards the growing body of knowledge on cannabis use.” She also mentioned her current research collaboration with Dr Tony George at the Centre for Addiction and Mental Health and her work with Dr Hedy Kober’s laboratory, where she studies the neurobiological mechanisms of craving and addiction, particularly in relation to cannabis.
The implications of these findings are far-reaching, particularly as cannabis becomes increasingly legalised and accessible in various parts of the world. The study’s authors emphasise the importance of educating adolescents about the potential mental health risks associated with cannabis use. They also call for the development of targeted interventions to prevent early cannabis use and mitigate its potential long-term effects on mental health.
Lowe emphasised the public health significance of this issue: “The hope is to continue to bridge existing gaps in order to better inform the public and guide more effective interventions and policies.”
